Cannabis Access Reduces Opioid Use in Cancer Care

For millions of people living with cancer, managing pain is one of the most difficult parts of treatment and recovery.  Opioids remain the standard option prescribed for cancer-related pain, but their long-term use can bring serious risks—dependence, side effects, and overdose.  A new national study¹ published in JAMA Health Forum suggests that cannabis access may be helping to reduce that reliance, building upon similar findings in recent months.

Researchers found that when medical or recreational cannabis dispensaries opened, opioid prescriptions for cancer patients dropped significantly.  The results add to a growing body of evidence suggesting that cannabis could serve as a safer complementary or substitute therapy for some patients who rely on prescription painkillers.

Inside the Study

The research team—led by Dr. Felipe Lozano-Rojas at the University of Georgia—analyzed insurance records from over 3 million cancer patients across the United States between 2007 and 2020.  Using data from Optum’s Clinformatics database, they compared states before and after the opening of medical cannabis dispensaries (MCDs) and recreational cannabis dispensaries (RCDs).

The results were striking.  After medical dispensaries opened, states saw a 24 percent drop in the rate of opioid prescriptions among cancer patients.  The average prescription length also shortened by about 2½ days, and the average number of opioid prescriptions per patient fell by 5 percent.  Recreational dispensary openings were also linked to reductions, though smaller, roughly half as large.

Swipe to scroll →

The study covered a diverse population—men and women aged 18–64 of various racial and ethnic backgrounds—and found the pattern consistent across all groups.  That suggests the association between cannabis availability and reduced opioid use was not limited to any one demographic.

What the Results Suggest

The findings point to an important takeaway: when cannabis is easier to access, opioid use tends to decline.

This doesn’t mean people are necessarily replacing all opioids with cannabis, but it does indicate that cannabis may serve as a substitute for at least part of pain management in certain patients.  Some may use cannabis to manage milder or breakthrough pain, allowing them to reduce opioid doses or avoid long-term prescriptions.

The study also hints that prescribers might be adapting.  In states with medical cannabis programs, doctors can check prescription-monitoring systems that record cannabis use.  Knowing that a patient uses medical cannabis could encourage physicians to prescribe lower opioid doses.  Even in recreational-use states, awareness of cannabis access might influence prescribing habits indirectly.

A Shift Toward Integrative Pain Relief

This is not the first research to suggest that cannabis and opioids interact in complex but potentially beneficial ways.  Earlier studies found that medical cannabis legalization was linked to fewer opioid prescriptions among Medicare patients and reduced opioid-related deaths at the population level.

What makes this new study stand out is its focus on cancer patients, a group that faces both extreme pain and complex medication challenges.  Many traditional pain medications have serious side effects or interact poorly with chemotherapy drugs.  Cannabis, in contrast, has been shown to ease pain, nausea, appetite loss, and anxiety—all common in cancer treatment—without the same overdose risks.

As one study on cannabis for cancer care noted, patients often report that cannabis helps by allowing better rest, appetite, and mood, even when opioids alone fall short.  Together, these benefits can improve the quality of life during and after treatment.

Why It Matters

The opioid crisis remains one of the largest public-health challenges in North America.  Cancer patients often depend on opioids for legitimate reasons, but the line between medical need and dependency risk can blur.

If cannabis can safely reduce opioid use, it could ease that burden.  However, researchers caution that the evidence so far is associational—the study tracked prescription trends, not direct cannabis use.  That means we don’t yet know whether the declines are caused by patients switching to cannabis, doctors prescribing differently, or broader policy effects.

Even so, the consistency of the data across multiple states and years makes the signal hard to ignore.

Complementary Insights: Cannabis, Opioids, and the Body

Emerging science supports the idea that cannabis and opioids may interact synergistically within the body’s pain-signaling pathways.  The endocannabinoid system—through CB1 and CB2 receptors—can modulate both inflammation and pain perception.  When cannabis compounds like THC and CBD activate these receptors, they can amplify pain relief from smaller opioid doses, a phenomenon called the opioid-sparing effect.

This could explain why some patients achieve the same pain control with fewer opioids when using cannabis.  A recent review on cannabis-derived compounds for pain reported similar findings: cannabinoids may enhance the body’s natural response to pain while reducing tolerance buildup seen with opioids.

What Comes Next

The authors stress that further research is needed, particularly studies that directly measure cannabis use among cancer patients.  They also call for an investigation into how dispensary accessibility, product types (like tinctures, edibles, or topicals), and patient education influence outcomes.

As more states legalize cannabis and expand medical programs, future research could explore:

• Whether patients maintain reduced opioid use long-term.
• How specific cannabinoids—like CBD or CBG—affect pain management and opioid interaction.
• What kinds of cannabis formulations are most effective for cancer pain.

For now, this study provides compelling evidence that cannabis access and opioid use are linked in meaningful ways, and that patients may benefit from policies that safely integrate cannabis into pain-care options.

A New Chapter in Cancer Pain Management

For decades, opioids have been the only reliable option for severe cancer pain. But this research suggests cannabis could be a valuable complement—helping patients reduce opioid reliance while improving comfort and quality of life.

As the study states, “This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain”.  For patients and physicians alike, that could mark a turning point in how we think about pain relief, compassion, and choice in cancer care.

References:

^{1. Lozano-Rojas, F., Bethel, V., Gupta, S., Steuart, S. R., Bradford, W. D., & Abraham, A. J. (2025). Cannabis laws and opioid use among commercially insured patients with cancer diagnoses. JAMA Health Forum, 6(10): e253512. https://doi.org/10.1001/jamahealthforum.2025.3512}